Chembio Diagnostics Inc
NASDAQ:CEMI
Chembio Diagnostics Inc
NASDAQ:CEMI
Price:
0.455 USD
0.22%
Market Closed
Updated:
May 1, 2024
Chembio Diagnostics Inc
Cash from Financing Activities
|
Chembio Diagnostics Inc
Cash from Financing Activities Peer Comparison
Comparables:
HAE
COO
XRAY
ALGN
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Chembio Diagnostics Inc
NASDAQ:CEMI
|
Cash from Financing Activities
$3.4m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
92%
|
CAGR 10-Years
52%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Cash from Financing Activities
$100.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cooper Companies Inc
NYSE:COO
|
Cash from Financing Activities
$116m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Financing Activities
-$307m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Financing Activities
-$598.3m
|
CAGR 3-Years
-129%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-34%
|
See Also
What is Chembio Diagnostics Inc's Cash from Financing Activities?
Cash from Financing Activities
3.4m
USD
3.4m
USD
Based on the financial report for Dec 31, 2022, Chembio Diagnostics Inc's Cash from Financing Activities amounts to 3.4m USD.
What is Chembio Diagnostics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
52%
52%
Over the last year, the Cash from Financing Activities growth was -91%. The average annual Cash from Financing Activities growth rates for Chembio Diagnostics Inc have been -43% over the past three years , 92% over the past five years , and 52% over the past ten years .
You don't have any saved screeners yet
